Literature DB >> 17470329

Race-related differences in heart failure therapies: simply black and white or shades of grey?

Gautam R Shroff1, Anne L Taylor, Monica Colvin-Adams.   

Abstract

The magnitude of burden imposed by heart failure on society has necessitated the evolution of innovative strategies to identify specific avenues of treatment and the populations at highest risk. Multiple studies have demonstrated a higher burden of cardiovascular disease in black Americans. It has also been shown that the clinical characteristics of heart failure, therapeutic targets, and response to various treatment modalities, are different in blacks as compared with whites. This article explores the unique race-related differences in heart failure with particular emphasis on the currently recommended therapeutic agents in heart failure.

Entities:  

Mesh：

Year:  2007        PMID： 17470329     DOI： 10.1007/bf02938347

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN： 1523-3782            Impact factor:   2.931


  29 in total

1.  A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure.

Authors:  Eric J Eichhorn; Michael J Domanski; Heidi Krause-Steinrauf; Michael R Bristow; Philip W Lavori
Journal:  N Engl J Med       Date:  2001-05-31       Impact factor: 91.245

Review 2.  Nitric oxide in endothelial dysfunction and vascular remodeling: clinical correlates and experimental links.

Authors:  R D Rudic; W C Sessa
Journal:  Am J Hum Genet       Date:  1999-03       Impact factor: 11.025

3.  Should drug therapy be personalized based on race?

Authors:  Eva M Vivian
Journal:  Ann Pharmacother       Date:  2006-02-28       Impact factor: 3.154

4.  Influence of blood pressure on the effectiveness of a fixed-dose combination of isosorbide dinitrate and hydralazine in the African-American Heart Failure Trial.

Authors:  Inder S Anand; S William Tam; Thomas S Rector; Anne L Taylor; Michael L Sabolinski; W Tad Archambault; Kirkwood F Adams; Adeoye Y Olukotun; Manuel Worcel; Jay N Cohn
Journal:  J Am Coll Cardiol       Date:  2006-12-14       Impact factor: 24.094

5.  Racial differences in the characteristics of patients admitted for acute decompensated heart failure and their relation to outcomes: results from the OPTIME-CHF trial.

Authors:  Melvin R Echols; G Michael Felker; Kevin L Thomas; Karen S Pieper; Jyotsna Garg; Michael S Cuffe; Mihai Gheorghiade; Robert M Califf; Christopher M O'Connor
Journal:  J Card Fail       Date:  2006-12       Impact factor: 5.712

6.  Racial variations in quality of care and outcomes in an ambulatory heart failure cohort.

Authors:  Anita Deswal; Nancy J Petersen; Diana L Urbauer; Steven M Wright; Rebecca Beyth
Journal:  Am Heart J       Date:  2006-08       Impact factor: 4.749

7.  Race, ethnicity and hospitalization for six chronic ambulatory care sensitive conditions in the USA.

Authors:  James N Laditka; Sarah B Laditka
Journal:  Ethn Health       Date:  2006-08       Impact factor: 2.772

8.  Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure.

Authors:  C W Yancy; M B Fowler; W S Colucci; E M Gilbert; M R Bristow; J N Cohn; M A Lukas; S T Young; M Packer
Journal:  N Engl J Med       Date:  2001-05-03       Impact factor: 91.245

Review 9.  Heart failure in African Americans.

Authors:  Clyde W Yancy
Journal:  Am J Cardiol       Date:  2005-08-09       Impact factor: 2.778

10.  Race-specific differences in endothelial function: predisposition of African Americans to vascular diseases.

Authors:  Leszek Kalinowski; Iwona T Dobrucki; Tadeusz Malinski
Journal:  Circulation       Date:  2004-05-24       Impact factor: 29.690
View more
  2 in total

1.  Racial and ethnic differences in incident hospitalized heart failure in postmenopausal women: the Women's Health Initiative.

Authors:  Charles B Eaton; Abdulrahman M Abdulbaki; Karen L Margolis; Joann E Manson; Marian Limacher; Liviu Klein; Matthew A Allison; Jennifer G Robinson; J David Curb; Lisa A Martin; Simin Liu; Barbara V Howard
Journal:  Circulation       Date:  2012-07-02       Impact factor: 29.690

2.  Disparity in race-specific comorbidities associated with central venous catheter-related bloodstream infection (AHRQ-PSI7).

Authors:  James Studnicki; Bola F Ekezue; Maka Tsulukidze; Peggy Honoré; Ramal Moonesinghe; John Fisher
Journal:  Am J Med Qual       Date:  2013-03-24       Impact factor: 1.852
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.